Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The End of the Beginning: COVID-19 Vaccines & Other Conundrums

Philip Seo, MD, MHS  |  Issue: January 2021  |  December 9, 2020

That still leaves 18%—59 million Americans—who have no interest in the vaccine. Who are these people, and can their minds be changed?

Trekkies & Trekkers
First, a lesson on nomenclature: anti-vaxxer is to vaccine hesitant as trekkie is to trekker. Both sets of terms refer to roughly similar groups of people, but there is nuance. The anti-vaxxers are the true believers; they will not be swayed by mere PowerPoint presentations. They will match you, slide for slide, with offbeat interpretations of questionable studies and nonsensical assertions of individual freedoms. They are like those who refuse to acknowledge the brilliance of Ricardo Montalbán’s performance in Star Trek II: Wrath of Khan. They are beyond hope or reason.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The vaccine hesitant comprise the reasonable reverse of the same coin. They do not doubt the science supporting the use of vaccines. They know that vaccines save lives. They’re just afraid. Or indifferent.16

The vaccine hesitant largely fall into three categories. The first is the hale and hearty, who largely think of COVID-19 as a problem for other people. They may even have friends who, also young and healthy, may have tested positive without ever having realized they were ill, which reinforces their viewpoint. The second category is ethnic minorities, who may not interact with the healthcare system on a regular basis or may bear some suspicion of organized healthcare, in general. The third category is the hyperinformed, the patients who show up to appointments with their Google searches and preprints, asking endless questions that have no good answer.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Sound like anyone you know?

I haven’t yet had many of these difficult conversations, but I know they are coming. And we should acknowledge they have a point. The history of vaccine rollouts has not been without tragedy. The worst example was the 1955 Cutter Incident, in which a manufacturing error allowed live polio to be mixed with the inactivated vaccine.17 The flawed vaccine sickened 40,000 children; 51 of these children were paralyzed, and five died. Even then, the company was not found to be negligent; a jury found it did the best it could with a novel, complex manufacturing process.

To reach the vaccine hesitant, we need to address their concerns head-on. For the unworried well, we need to convince them that getting vaccinated is an act of altruism, somewhere between running into a burning building and helping a little old lady cross the street. It is the young and healthy who are most likely to have an asymptomatic or minimally symptomatic infection, which they can unknowingly transmit to others. They may not benefit directly from the vaccine, but vaccination may prevent them from inadvertently infecting someone they love.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:COVID-19

Related Articles

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

    July 6, 2021

    Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

    Anze Furlan / SHUTTERSTOCK.COM

    How Immunosuppression May Affect COVID-19 Vaccine Response

    June 13, 2021

    Although we can expect to learn much more, preliminary data are now available on the potential safety and effectiveness of COVID-19 vaccines in rheumatology patients. The picture is likely to be nuanced, with not all types of immuno­suppressive treatments having identical impacts on vaccine response. Rheumatologists should use caution in interpreting early reports, while continuing…

    ACR Convergence 2020

    ACR Convergence 2020: Progress Toward COVID-19 Vaccines

    November 11, 2020

    ACR CONVERGENCE 2020—A scientific session on Sunday, Nov. 8, focused on vaccine prospects in COVID-19. Dan Barouch, MD, PhD, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and the William Bosworth Castle Professor of Medicine at Harvard Medical School in Boston, shared his insights about vaccine development across…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences